Evidence map›Paper›PMID 32499159›Full record

ArticleResearch in social & administrative pharmacy : RSAP2021

Community pharmacists' exposure to COVID-19.

Paolo Cabas, Stefano Di Bella, Mauro Giuffrè, Michele Rizzo, Carlo Trombetta, Roberto Luzzati, Roberta Maria Antonello, Ketty Parenzan, Giovanni Liguori

Open access · greenAbstract read
In one paragraph

Article in Research in social & administrative pharmacy : RSAP, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. COVID-19 and healthcare workers: A systematic review and meta-analysis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Assessment of the Consultation Rate with General Practitioners in the Initial Phase of the COVID-19 Pandemic.International journal of environmental research and public health · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Paolo CabasCattinara Hospital, Department of Urology, University of Trieste, Strada di Fiume 447, Trieste, 34149, Italy. Electronic address: paolo.cabas@asuits.sanita.fvg.it.
Stefano Di BellaMaggiore Hospital, Department of Infectious Disease, University of Trieste, Piazza dell'Ospitale 1, Trieste, 34125, Italy. Electronic address: stefano.dibella@asuits.sanita.fvg.it.
Mauro GiuffrèDepartment of Medical, Surgical and Health Sciences, Cattinara Hospital, Liver Clinic Unit, University of Trieste, Strada di Fiume 447, Trieste, 34149, Italy. Electronic address: mauro.giuffre@asuits.sanita.fvg.it.
Michele RizzoMaggiore Hospital, Department of Infectious Disease, University of Trieste, Piazza dell'Ospitale 1, Trieste, 34125, Italy. Electronic address: michele.rizzo@asuits.sanita.fvg.it.
Carlo TrombettaCattinara Hospital, Department of Urology, University of Trieste, Strada di Fiume 447, Trieste, 34149, Italy. Electronic address: trombcar@units.it.
Roberto LuzzatiUniversity of Trieste, Piazzale Europa 1, Trieste, 34125, Italy. Electronic address: roberto.luzzati@asuits.sanita.fvg.it.
Roberta Maria AntonelloUniversity of Trieste, Piazzale Europa 1, Trieste, 34125, Italy. Electronic address: rma.roby@gmail.com.
Ketty ParenzanCattinara Hospital, Pharmacy, University of Trieste, Strada di Fiume 447, Trieste, 34149, Italy. Electronic address: ketty.parenzan@asuits.sanita.fvg.it.
Giovanni LiguoriCattinara Hospital, Department of Urology, University of Trieste, Strada di Fiume 447, Trieste, 34149, Italy. Electronic address: gliguori@units.it.
University of Trieste · ITOspedale di Cattinara · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSince the beginning of the 2020 Sars-CoV-2 Italian outbreak, healthcare workers have been among the most exposed categories. There is little information about community pharmacists' on occupational exposure, symptoms development, and testing practices in the community pharmacist cohort.

methodsBetween April 30th and May 10th, a questionnaire was administered through social media to Italian community pharmacists. From 67000 pharmacists currently working in community pharmacies, 1632 answered the survey.

resultsThe survey population reflected the general Italian community pharmacists population in terms of age, gender, and number of co-workers. Protective measures were adopted in up to 99.9% of pharmacies. 624 pharmacists (38.2%) developed at least one COVID-19 related symptom in the period between February 28th and May 10th. Also, 102 pharmacists (6.2%) were tested for COVID-19 and 15, the 15% of the tested population and 0.92% of the whole survey population, resulted positive on nasopharyngeal swab. However, while the number of symptomatic pharmacists decreased, a higher number of tests were performed, thus COVID-19 prevalence among community pharmacists could have been underestimated and is probably intermediate between other healthcare workers and the general population (0.31%).

conclusionCommunity pharmacists have probably been one of the first categories to experience increased contact risk to SARS-CoV-2. COVID-19 prevalence among pharmacists could have been underestimated. In addition, the rates of protection measures adoption might have helped to reduce the spread of COVID-19 among co-workers and the community.

Indexed as

Community Pharmacy ServicesAdultCOVID-19COVID-19 TestingFemaleHumansItalyMaleOccupational ExposurePharmacistsPrevalenceSurveys and QuestionnairesCommunity pharmacistsCOVID-19Healthcare workers

Identifiers

PMID32499159
PMCPMC7255346
OpenAlexW3029602388

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.